● Recruiting

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Condition: Moderate-to-severe Chronic Plaque Psoriasis · Sponsor: Vanda Pharmaceuticals

PhasePhase 3

Planned participants300

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

An open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis

This description comes directly from the study's public registry record.

Talk to the study team

Vanda Pharmaceuticals, Inc. · 202-734-3400 · clinicaltrials@vandapharma.com

Always discuss trial participation with your own doctor first.

Locations (4)

Vanda Investigational Site	Glendale, Arizona, United States	Recruiting
Vanda Investigational Site	Fremont, California, United States	Recruiting
Vanda Investigational Site	Rochester, New York, United States	Recruiting
Vanda Investigational Site	Spokane, Washington, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07362017